Therefore, it was suggested that genistein had a neuroprotective effect in this AD model and that the mechanism of this effect may be related to the down-regulation of the CaM-CaMKIV signaling pathway and tau protein expression [47]. This evidence concerns the gene CAMK4 and Alzheimer disease.